NCT05050669View on ClinicalTrials.gov

Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

April 27, 2022

Primary Completion Date

August 17, 2023

Study Completion Date

June 26, 2024

Conditions
Ectonucleotide Pyrophosphatase/phosphodiesterase1 DeficiencyATP-Binding Cassette Subfamily C Member 6 DeficiencyGeneralized Arterial Calcification of InfancyAutosomal Recessive Hypophosphatemic Rickets
Interventions
OTHER

No Intervention for this observational study

No Intervention for this observational study

Trial Locations (5)

19146

CHOP - Robers Center for Pediatric Research, Philadelphia

76104

Cook Children's Hospital, Fort Worth

02115

Boston Children's Hospital, Boston

H3T 1C5

CHU Sainte-Justine, Montreal

M13 9WL

Royal Manchester University Hospital, Manchester

Sponsors

Lead Sponsor

Inozyme Pharma
All Listed Sponsors
lead

Inozyme Pharma

INDUSTRY

NCT05050669 - Natural History Study of ENPP1 Deficiency and the Early-onset Form of ABCC6 Deficiency | Biotech Hunter | Biotech Hunter